Screener
Zymeworks ZYME Issuance costs related to sale of future royalties not yet paid
Issuance costs related to sale of future royalties not yet paid at other companies
Other financials
Where this comes from
Reported directly by Zymeworks in its filing.
Tagged under the XBRL concept zyme:IssuanceCostsRelatedToSaleOfFutureRoyaltiesNotYetPaid.
The source filing: Zymeworks’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001937653-26-000034
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Cash and cash equivalents, beginning of period | 41,157 | 66,103 |
| Cash and cash equivalents, end of period | $244,282 | $76,204 |
| Supplemental cash flow information: | ||
| Net cash paid during the period for income taxes | $245 | $387 |
| Supplemental disclosure of non-cash investing and financing items: | ||
| Leased assets obtained in exchange for operating lease liabilities | — | 765 |
| Issuance costs related to sale of future royalties not yet paid | 1,176 | — |
| Acquisition of property and equipment and intangible assets not yet paid | 100 | 81 |
Item 1. Financial Statements
FAQ
- What is Zymeworks's issuance costs related to sale of future royalties not yet paid?
- Zymeworks (ZYME) reported issuance costs related to sale of future royalties not yet paid of $1.18M in Q1 2026.
- What does issuance costs related to sale of future royalties not yet paid mean?
- Issuance costs related to sale of future royalties not yet paid as reported by Zymeworks Inc..
Ask your AI about Zymeworks's issuance costs related to sale of future royalties not yet paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude